Top Clinical Trials companies in India by Gross Profit Margin

This ranking features the top 75 Clinical Trials companies in India ranked by Gross Profit Margin, averaging a Gross Profit Margin of 41.76%, for February 12, 2025.

India

Clinical Trials
Gross Profit Margin
#
Name
Gross Profit Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
INDGN.NS

Indegene Limited

1

INDGN.NS
97.73%
March 31, 2024 USD 6.80 -3.84%

India
2
SUVEN.NS

Suven Life Sciences Limited

2

SUVEN.NS
92.95%
March 31, 2024 USD 1.38 -6.89%

India
3
NATCOPHARM.NS

NATCO Pharma Limited

3

NATCOPHARM.NS
78.45%
March 31, 2024 USD 14.31 -2.32%

India
4
VIMTALABS.NS

Vimta Labs Limited

4

VIMTALABS.NS
76.03%
March 31, 2024 USD 12.04 -1.03%

India
5
CONCORDBIO.NS

Concord Biotech Limited

5

CONCORDBIO.NS
75.47%
March 31, 2024 USD 24.55 -3.90%

India
6
PGHL.NS

Procter & Gamble Health Limited

6

PGHL.NS
71.29%
June 30, 2024 USD 60.61 -0.51%

India
7
MANKIND.NS

Mankind Pharma Limited

7

MANKIND.NS
68.37%
March 31, 2024 USD 28.23 -1.30%

India
8
CIPLA.NS

Cipla Limited

8

CIPLA.NS
64.91%
March 31, 2024 USD 16.74 0.39%

India
9
PFIZER.NS

Pfizer Limited

9

PFIZER.NS
63.74%
March 31, 2024 USD 47.36 -2.46%

India
10
THEMISMED.NS

Themis Medicare Limited

10

THEMISMED.NS
63.39%
March 31, 2024 USD 2.42 -3.82%

India
11
IPCALAB.NS

Ipca Laboratories Limited

11

IPCALAB.NS
62.64%
March 31, 2024 USD 16.36 -1.17%

India
12
BIOCON.NS

Biocon Limited

12

BIOCON.NS
62.17%
March 31, 2024 USD 4.17 -3.26%

India
13
GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

13

GLAXO.NS
58.89%
March 31, 2024 USD 23.71 -3.13%

India
14
DRREDDY.NS

Dr. Reddy's Laboratories Limited

14

DRREDDY.NS
58.61%
March 31, 2024 USD 13.94 -0.13%

India
15
LYKALABS.NS

Lyka Labs Limited

15

LYKALABS.NS
57.44%
March 31, 2024 USD 1.51 -1.73%

India
16
CALSOFT.NS

California Software Company Limited

16

CALSOFT.NS
57.18%
March 31, 2024 USD 0.14 -2.51%

India
17
SUVENPHAR.NS

Suven Pharmaceuticals Limited

17

SUVENPHAR.NS
57.17%
March 31, 2024 USD 12.49 -2.13%

India
18
SANOFI.NS

Sanofi India Limited

18

SANOFI.NS
55.90%
Dec. 31, 2023 USD 61.89 -0.04%

India
19
AUROPHARMA.NS

Aurobindo Pharma Limited

19

AUROPHARMA.NS
55.22%
March 31, 2024 USD 13.22 -1.73%

India
20
GLAND.NS

Gland Pharma Limited

20

GLAND.NS
54.73%
March 31, 2024 USD 16.72 -0.99%

India
21
NEULANDLAB.NS

Neuland Laboratories Limited

21

NEULANDLAB.NS
52.92%
March 31, 2024 USD 157.44 -6.12%

India
22
GRANULES.NS

Granules India Limited

22

GRANULES.NS
52.72%
March 31, 2024 USD 6.36 -2.20%

India
23
PANACEABIO.NS

Panacea Biotec Limited

23

PANACEABIO.NS
51.90%
March 31, 2024 USD 4.07 -9.29%

India
24
LUPIN.NS

Lupin Limited

24

LUPIN.NS
51.67%
March 31, 2024 USD 23.82 -3.94%

India
25
ERIS.NS

Eris Lifesciences Limited

25

ERIS.NS
51.47%
March 31, 2024 USD 15.36 -4.42%

India
26
ZIMLAB.NS

ZIM Laboratories Limited

26

ZIMLAB.NS
50.60%
March 31, 2024 USD 1.14 -4.23%

India
27
GUFICBIO.NS

Gufic Biosciences Limited

27

GUFICBIO.NS
50.50%
March 31, 2024 USD 4.54 -3.97%

India
28
MARKSANS.NS

Marksans Pharma Limited

28

MARKSANS.NS
49.75%
March 31, 2024 USD 2.90 -5.10%

India
29
METROPOLIS.NS

Metropolis Healthcare Limited

29

METROPOLIS.NS
48.13%
March 31, 2024 USD 20.54 -0.02%

India
30
ASTRAZEN.NS

AstraZeneca Pharma India Limited

30

ASTRAZEN.NS
48.03%
March 31, 2024 USD 85.79 -0.54%

India
31
WANBURY.NS

Wanbury Limited

31

WANBURY.NS
46.29%
March 31, 2024 USD 2.48 -5.72%

India
32
ZYDUSLIFE.NS

Zydus Lifesciences Limited

32

ZYDUSLIFE.NS
45.66%
March 31, 2024 USD 10.85 -1.55%

India
33
SAKAR.NS

Sakar Healthcare Limited

33

SAKAR.NS
45.38%
March 31, 2024 USD 2.87 -3.41%

India
34
BAJAJHCARE.NS

Bajaj HealthCare Limited

34

BAJAJHCARE.NS
45.26%
March 31, 2024 USD 6.81 -4.55%

India
35
TORNTPHARM.NS

Torrent Pharmaceuticals Limited

35

TORNTPHARM.NS
44.09%
March 31, 2024 USD 35.78 -1.94%

India
36
THYROCARE.NS

Thyrocare Technologies Limited

36

THYROCARE.NS
43.77%
March 31, 2024 USD 8.63 -2.94%

India
37
INDSWFTLTD.NS

Ind-Swift Limited

37

INDSWFTLTD.NS
43.24%
March 31, 2024 USD 0.17 -4.25%

India
38
SEQUENT.NS

Sequent Scientific Limited

38

SEQUENT.NS
42.53%
March 31, 2024 USD 1.75 -2.24%

India
39
KILITCH.NS

Kilitch Drugs (India) Limited

39

KILITCH.NS
40.19%
March 31, 2024 USD 3.70 0.83%

India
40
ORCHPHARMA.NS

Orchid Pharma Limited

40

ORCHPHARMA.NS
38.59%
March 31, 2024 USD 14.32 -3.90%

India
41
JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

41

JBCHEPHARM.NS
38.46%
March 31, 2024 USD 18.58 -3.14%

India
42
SUPRIYA.NS

Supriya Lifescience Limited

42

SUPRIYA.NS
36.96%
March 31, 2024 USD 7.86 -5.01%

India
43
VENUSREM.NS

Venus Remedies Limited

43

VENUSREM.NS
36.90%
March 31, 2024 USD 3.61 -11.36%

India
44
APLLTD.NS

Alembic Pharmaceuticals Limited

44

APLLTD.NS
36.43%
March 31, 2024 USD 10.00 -1.50%

India
45
FDC.NS

FDC Limited

45

FDC.NS
33.63%
March 31, 2024 USD 5.32 1.01%

India
46
KOPRAN.NS

Kopran Limited

46

KOPRAN.NS
33.54%
March 31, 2024 USD 1.96 -3.91%

India
47
IOLCP.NS

IOL Chemicals and Pharmaceuticals Limited

47

IOLCP.NS
33.28%
March 31, 2024 USD 4.24 -2.07%

India
48
ABBOTINDIA.NS

Abbott India Limited

48

ABBOTINDIA.NS
33.27%
March 31, 2024 USD 335.54 -1.09%

India
49
STAR.NS

Strides Pharma Science Limited

49

STAR.NS
32.86%
March 31, 2024 USD 7.96 -5.16%

India
50
BLISSGVS.NS

Bliss GVS Pharma Limited

50

BLISSGVS.NS
32.57%
March 31, 2024 USD 1.65 -3.32%

India
Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Gross Profit Margin ?

    The Clinical Trials company in India with the highest Gross Profit Margin is Indegene Limited (NSE: INDGN.NS) at 97.73%.

  • Which Clinical Trials company in India has the lowest Gross Profit Margin ?

    The Clinical Trials company in India with the lowest Gross Profit Margin is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at -163.91%.

SV Wall Street